Table 2: VL management practices: observation of doctor patient consultations.

IndiaNepalBangladeshOverall
20092010200920102009201020092010

No. of doctor-patient consultations observed: 1st visit( 𝑛 = 2 3 )( 𝑛 = 2 3 )( 𝑛 = 3 )( 𝑛 = 1 2 )( 𝑛 = 5 )( 𝑛 = 1 8 )( 𝑛 = 3 1 )( 𝑛 = 5 3 )
Follow-up visit( 𝑛 = 1 3 )( 𝑛 = 0 )( 𝑛 = 0 )( 𝑛 = 0 )( 𝑛 = 1 7 )( 𝑛 = 2 0 ) ( 𝑛 = 3 0 )( 𝑛 = 2 0 )

(i) Doctor asked patient for family h/o VL at 1st visit13/23
(57%)
11/23
(48%)
3/3
(100%)
9/12
(75%)
5/5
(100%)
18/18
(100%)
21/31
(68%)
38/53
(72%)
(ii) Doctor asked about pregnancy at 1st visit of women of reproductive age5/7
(71%)
6/6
(100%)
1/6
(17%)
1/1
(100%)
6/8
(75%)
7/12
(58%)
(iii) Doctor advised drug dose based on patient’s weight at 1st visit22/23
(96%)
23/23
(100%)
3/3
(100%)
10/12
(83%)
5/5
(100%)
18/18
(100%)
30/31
(97%)
51/53
(96%)
(iv) Temperature of patient was measured23/36
(64%)
23/23
(100%)
3/3
(100%)
5/12
(42%)
5/22
(23%)
18/38
(47%)
31/61
(51%)
46/73
(63%)
(v) Doctor examined patient for spleen enlargement23/36
(64%)
23/23
(100%)
3/3
(100%)
12/12
(100%)
5/22
(23%)
18/38
(47%)
31/61
(51%)
53/73
(73%)
(vi) Doctor advised blood tests for patient21/36
(58%)
20/23
(87%)
3/3
(100%)
5/12
(42%)
3/22
(14%)
12/38
(32%)
27/61
(44%)
37/73
(51%)
(vii) On FU visit, doctor asked patient for side effects13/13
(100%)
1/17
(6%)
19/20
(95%)
14/30
(47%)
19/20
(95%)